Carolina Chabrera1, Adelaida Zabalegui, Marta Bonet, Mónica Caro, Joan Areal, Juan R González, Albert Font. 1. Author Affiliations: School of Health Science-TecnoCampus, Department of Nursing, University Pompeu Fabra, Mataró (Ms Chabrera); Departments of Oncology (Ms Chabrera and Dr Font) and Radiation Oncology (Dr Caro), Catalan Institute of Oncology, Badalona; Hospital Clinic, Barcelona (Dr Zabalegui); Oncology Institute of Vallés, Terrassa (Dr Bonet); Department of Urology, University Hospital Germans Trias i Pujol, Badalona (Dr Areal); and Center for Research in Environmental Epidemiology-CREAL, Barcelona (Dr González), Spain.
Abstract
BACKGROUND: Decision aids provide balanced information about the benefits and risks of treatment options and improve the match between patient preferences and the treatment received. OBJECTIVE: To assess the impact of a decision aid regarding the treatment options for patients with localized prostate cancer. METHODS: A 2-arm randomized controlled trial was used to compare booklet patient decision aid (interventiongroup n = 61) with standard information for localized prostate cancer (control group n = 61). The study was conducted at 3 hospitals between 2011 and 2013. The main outcome measures were knowledge, decisional conflict, satisfaction with the decision-making process, and coping. RESULTS: The respective mean Decisional Conflict Scale scores before and after the intervention were 53.0 ± 16.9 and 31.2 ± 10.2 in the intervention group and 49.1 ± 13.7 and 51.7 ± 13.3 in the control group (P < .001). Mean Knowledge scores were 38.6 ± 16.5 and 75.7 ± 19.0 in the intervention group and 42.0 ± 17.6 and 49.9 ± 16.0 in the control group (P < .001). Mean Satisfaction With Decision Scale scores were 81.1 ± 8.92 and 95.7 ± 6.89 in the intervention group and 82.5 ± 12.0 and 79.3 ± 10.3 in the control group (P < .001). CONCLUSIONS: Decision aid not only improved patient knowledge about localized prostate cancer and its treatment and their satisfaction with decision making but also decreased their decisional conflict. IMPLICATIONS FOR PRACTICE: Decision aid represents a rather innovative approach for a health insurance fund to develop and offer this format of information and decision support. This opens a new field of study for nurses to empower patients in the decision-making process and develop new roles in this area.
RCT Entities:
BACKGROUND: Decision aids provide balanced information about the benefits and risks of treatment options and improve the match between patient preferences and the treatment received. OBJECTIVE: To assess the impact of a decision aid regarding the treatment options for patients with localized prostate cancer. METHODS: A 2-arm randomized controlled trial was used to compare booklet patient decision aid (intervention group n = 61) with standard information for localized prostate cancer (control group n = 61). The study was conducted at 3 hospitals between 2011 and 2013. The main outcome measures were knowledge, decisional conflict, satisfaction with the decision-making process, and coping. RESULTS: The respective mean Decisional Conflict Scale scores before and after the intervention were 53.0 ± 16.9 and 31.2 ± 10.2 in the intervention group and 49.1 ± 13.7 and 51.7 ± 13.3 in the control group (P < .001). Mean Knowledge scores were 38.6 ± 16.5 and 75.7 ± 19.0 in the intervention group and 42.0 ± 17.6 and 49.9 ± 16.0 in the control group (P < .001). Mean Satisfaction With Decision Scale scores were 81.1 ± 8.92 and 95.7 ± 6.89 in the intervention group and 82.5 ± 12.0 and 79.3 ± 10.3 in the control group (P < .001). CONCLUSIONS: Decision aid not only improved patient knowledge about localized prostate cancer and its treatment and their satisfaction with decision making but also decreased their decisional conflict. IMPLICATIONS FOR PRACTICE: Decision aid represents a rather innovative approach for a health insurance fund to develop and offer this format of information and decision support. This opens a new field of study for nurses to empower patients in the decision-making process and develop new roles in this area.
Authors: Donna L Berry; Fangxin Hong; Traci M Blonquist; Barbara Halpenny; Christopher P Filson; Viraj A Master; Martin G Sanda; Peter Chang; Gary W Chien; Randy A Jones; Tracey L Krupski; Seth Wolpin; Leslie Wilson; Julia H Hayes; Quoc-Dien Trinh; Mitchell Sokoloff; Prabhakara Somayaji Journal: J Urol Date: 2017-07-25 Impact factor: 7.450
Authors: Joseph D Shirk; Catherine M Crespi; Josemanuel D Saucedo; Sylvia Lambrechts; Ely Dahan; Robert Kaplan; Christopher Saigal Journal: Patient Date: 2017-12 Impact factor: 3.883
Authors: R Schaffert; U Dahinden; T Hess; A Bänziger; P Kuntschik; F Odoni; P Spörri; R T Strebel; J Kamradt; G Tenti; A Mattei; M Müntener; S Subotic; H-P Schmid; P Rüesch Journal: Urologe A Date: 2018-02 Impact factor: 0.639
Authors: Charlotte J Hagerman; Paula G Bellini; Kim M Davis; Richard M Hoffman; David S Aaronson; Daniel Y Leigh; Riley E Zinar; David Penson; Stephen Van Den Eeden; Kathryn L Taylor Journal: Health Educ Res Date: 2017-04-01
Authors: Brindha Pillay; Daniel Moon; Denny Meyer; Helen Crowe; Sarah Mann; Nicholas Howard; Addie Wootten; Mark Frydenberg Journal: Support Care Cancer Date: 2019-05-08 Impact factor: 3.603
Authors: Shailin A Thomas; Mutita Siriruchatanon; Stephanie L Albert; Marc Bjurlin; Jason C Hoffmann; Aisha Langford; R Scott Braithwaite; Danil V Makarov; Angela Fagerlin; Stella K Kang Journal: J Am Coll Radiol Date: 2022-06-15 Impact factor: 6.240
Authors: Jon C Tilburt; David Zahrieh; Joel E Pacyna; Daniel G Petereit; Judith S Kaur; Bruce D Rapkin; Robert L Grubb; George J Chang; Michael J Morris; Evan Z Kovac; Kara N Babaian; Jeff A Sloan; Ethan M Basch; Elizabeth S Peil; Amylou C Dueck; Paul J Novotny; Electra D Paskett; Jan C Buckner; Daniel D Joyce; Victor M Montori; Dominick L Frosch; Robert J Volk; Simon P Kim Journal: Cancer Date: 2021-12-10 Impact factor: 6.921
Authors: Lixin Song; Christina Tyler; Margaret F Clayton; Eleanor Rodgiriguez-Rassi; Latorya Hill; Jinbing Bai; Raj Pruthi; Donald E Bailey Journal: Patient Educ Couns Date: 2016-09-23
Authors: N B Jalil; P Y Lee; M Z Nor Afiah; K L Abdullah; F N S Mohd Azizi; N N S Abdul Rassip; T A Ong; C J Ng; Y K Lee; A T Cheong; A H Razack; M Saad; A Alip; R Malek; M Sundram; S Omar; J R Sathiyananthan; P Kumar Journal: J Cancer Educ Date: 2022-02 Impact factor: 2.037